Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-05-13 @ 12:43 PM
Study NCT ID:
NCT02338232
Status:
TERMINATED
Last Update Posted:
2024-05-01
First Post:
2015-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor:
Hackensack Meridian Health
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | GVHD | View |
Keywords: